Matthew J Bernett

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Benign Prostatic Hyperplasia

Mesenchymal Stem Cells

Endoplasmic Reticulum Stress

Top Venues

Molecular cancer therapeutics

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Li, Peiyin Wang, Dionysos Slaga, Kendra N Avery, Ke Liu, Suzanne Schubbert, Rajat Varma, Eugene Y Chiang, Klara Totpal, Matthew J Bernett, Patrick G Holder, Teemu T Junttila
IL-15/IL-15Rα-Fc fusion protein XmAb24306 potentiates activity of CD3 bispecific antibodies through enhancing T cell expansion. Molecular cancer therapeutics (2024)
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan Case, Christopher M Murawsky, Bram Estes, Gregory L Moore, Matthew J Bernett, Umesh S Muchhal, John R Desjarlais, Binnaz K Staley, Jennitte L Stevens, Keegan S Cooke, Famke Aeffner, Oliver Thomas, Julia Stieglmaier, Jae Lyun Lee, Angela Coxon, Julie M Bailis
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. Cancer discovery (2023)